Search results
Author(s):
Ngoc Huy Nguyen
,
Thanh Ngoc Le
,
Hoai Thi Thu Nguyen
,
et al
Added:
5 months ago
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
3 months ago
ESC Congress 2025 – The fourth and final day of ESC Congress 2025 maintained momentum with transformative clinical data that will influence cardiovascular practice worldwide.Leading interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) offer their expert commentary on the standout hot line trials and their clinical significance from day four.Day 4…
View more
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
3 months ago
ESC Congress 2025 – Day 3 of ESC Congress 2025 continued to deliver groundbreaking research with pivotal studies shaping the future of cardiovascular medicine.Interventional cardiologists Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) provide their comprehensive breakdown of the most impactful hot line trial results from the day's sessions.Day 3 Highlights…
View more
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
3 months ago
ESC Congress 2025 – The second day of ESC Congress 2025 brought forth significant findings with major implications for cardiovascular care.Interventional specialists Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) share their expert analysis of the essential insights from the day's hot line trial presentations.Day 2 Highlights:MAPLE-HCMODYSSEY-HCMBETAMI…
View more
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
3 months ago
ESC Congress 2025 - The opening day of ESC Congress 2025 delivered compelling new developments as updated clinical practice guidelines were released alongside a series of eagerly awaited Hot Line trials.Leading interventional cardiologists, Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) present focused overviews of the most significant Hot Line and Late…
View more
Author(s):
Thomas Modine
Added:
6 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
1 year ago
ESC Congress 24 – Day 1 of the ESC Congress 2024 was filled with excitement as new clinical practice guidelines were unveiled, along with several highly anticipated Hot Line trials.Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) are concluding the first day by providing practical summaries of the key guidelines and offering critical insights…
View more
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
1 year ago
ESC Congress 24 – Day 4 of the ESC Congress 2024 was filled with hot line and late-breaking data poised to influence cardiovascular practice.Interventional experts DrMirvat Alasnagand DrKhaled Al-Shaibi(King Fahd Armed Forces Hospital, SA) joined us to review and distil the key messages from the latest data presented at the last of the biggest cardiovascular event of 2024.Day 4 Highlights:00:19…
View more
Author(s):
Mirvat Alasnag
,
Khaled Al-Shaibi
Added:
2 years ago
ESC 23 — We are joined by Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful wrap-up of the final day of ESC Congress 2023.
New data releases covered in detail include:
OPT-BIRISK
NITRATE-CIN
Recorded on-site at ESC Congress 2023, Amsterdam.
Editors: Mirjam Boros and Jordan Rance
Video Specialists: Dan Brent, Tom Green, Mike Knight,…
View more
e-SPACE CRM 2024 - Day 2
Author(s):
Antonio Ceriello
,
Ileana L Piña
,
Gianluigi Savarese
,
et al
Start date:
Mar 23, 2024
Broadcast